Intermittent claudication in 8343 men and 21-year specific mortality follow-up

Annals of Epidemiology

Volumn 7, Issue 3, 1997, Pages 180-187

  Bowlin, Steven J ^a   Medalie, Jack H ^a   Flocke, Susan A ^a   Zyzanski, Stephen J ^a   Yaari, Shlomit ^b   Goldbourt, Uri ^c,d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAR ILAN UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INCIDENCE; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL;

ADULT; AGED; CEREBROVASCULAR DISORDERS; FOLLOW-UP STUDIES; FORECASTING; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 0030924391     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(96)00148-2     Document Type: Article

References (41)

1. Dormandy JA. Natural history of patients with peripheral occlusive arterial disease. Ann Chir Gynecol. 1992;81:86-88.
2. Dormandy J, Mahir M, Ascady G, et al. Fate of the patient with chronic leg ischaemia. J Cardiovasc Surg. 1989;30:50-57.
3. Pack Claudication Substudy Investigators. Randomized placebo-controlled, double-blind trial of Ketanserin in claudicants: Changes in claudication distance and ankle systolic pressure. Circulation. 1989;80:1544-1548.
4. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: The Framingham Study. J Am Geriatr Soc. 1985;33:13-18.
5. Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: A review. J Clin Epidemiol. 1992;45:529-542.
6. Bowlin SJ, Medalie JH, Flocke SA, Zyzanski J, Goldbourt U. Epidemiology of intermittent claudication in middle-aged men. Am J Epidemiol. 1994;140:418-430.
7. Silbert S, Zazeela H. Prognosis in arteriosclerotic peripheral vascular disease. JAMA. 1958;166:1816-1821.
8. Juergens JL, Barker NW, Hines EA. Arteriosclerosis obliterans: Review of 520 cases with special reference to pathogenic and prognostic factors. Circulation. 1960;21:188-195.
9. Singer A, Rob C. The fate of the claudicator. Br Med J. 1960;2:633-6.
10. Bloor K. Natural history of arteriosclerosis of the lower extremities. Ann Roy Coll Surg Engl. 1961;28:36-52.
11. Taylor GW, Calo AR. Atherosclerosis of arteries of lower limbs. Br Med J. 1962;1:507-10.
12. McAllister FF. The fate of patients with intermittent claudication managed nonoperatively. Am J Surg. 1976;132:593-595.
13. Hughson WG, Mann JI, Tibbs DJ, Woods HF, Walton I. Intermittent claudication: Factors determining outcome. Br Med J. 1978;1:1377-1379.
14. Wilson SE, Schwartz I, Williams RA, Owens ML. Occlusion of the superficial femoral artery. What happens without operation. Am J Surg. 1980;140:112-118.
15. Kallero KS. Mortality and morbidity in patients with intermittent claudication as defined by venous occlusion plethysmography. A ten-year follow-up study. J Chron Dis. 1981;34;455-462.
16. Cronenwett JL, Warner KG, Zelenock GB, et al. Intermittent claudication Current results of nonoperative management. Arch Surg. 1984;119:430-436.
17. Jonason T, Ringqvist I. Mortality and morbidity in patients with intermittent claudication in relation to the location of the occlusive atherosclerosis in the leg. Angiology. 1985;36:310-314.
18. Jelnes R, Gaardsting O, Jensen KH, Baekgaard N, Tonnesen KH, Schroeder T. Fate in intermittent claudication: Outcome and risk factors. Br Med J. 1986;293:1137-1140.
19. Jonason T, Bergstrom R. Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand. 1987;221:253-260.
20. Rosenbloom MS, Flanigan DP, Schuler JJ, et al. Risk factors affecting the natural history of intermittent claudication. Arch Surg. 1988;123:867-870.
21. Howell MA, Colgan MP, Seeger RW, Ramsey DE, Sumner DS. Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: A six-year follow-up study. J Vasc Surg. 1989;9:691-697.
22. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119-128.
23. O'Riordain DS, O'Donnell JA. Realistic expectations for the patient with intermittent claudication. Br J Surg. 1991;78:861-863.
24. Kannel WB, Skinner JJ, Schwartz MJ, Schurtleff D. Intermittent claudication: Incidence in the Framingham Study. Circulation. 1970;41: 875-883.
25. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-386.
26. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality: The Whitehall Study. Circulation. 1990;82:1925-1931.
27. Agner E. Natural history of angina pectoris, possible previous myocardial infarction and intermittent claudication during the eighth decade: A longitudinal epidemiologic study. Acta Med Scand. 1981;210: 271-276.
28. Reunanen A, Takkunen H, Aromaa A. Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand. 1982;211:249-256.
29. Harmsen P, Rosengren A, Tsipogianni A, Wilhelmsen L. Risk factors for stroke in middle-aged men in Goteborg, Sweden. Stroke. 1990;21:223-229.
30. Vogt MT, McKenna M, Wolfson SK, Kuller LH. The relationship between ankle brachial index, other atherosclerotic disease, diabetes, smoking and mortality in older men and women. Atherosclerosis. 1993;101:191-202.
31. Shaper AG, Wannamethee SG, Walker MK. Risk factors and cardiovascular outcome: Calf Pain on Walking, Risk Factors and Cardiovascular Outcome in Middle-Aged British Men. In: Fowkes FGR, ed. Epidemiology of Peripheral Vascular Disease. London: Springer-Verlag; 1991:127-140.
32. Groen JJ, Medalie JH, Neufeld HN, et al. An epidemiologic investigation of hypertension and ischemic heart disease within a defined segment of the adult male population of Israel. Israel J Med Sci. 1968;4:177-194.
33. Medalie JH, Kahn HA, Neufeld HN, et al. Myocardial infarction over a five-year period. I. Prevalence, incidence and mortality experience. J Chron Dis. 1973;26:63-84.
34. Rose GA. The Diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull WHO. 1962;27:645-658.
35. Medalie JH, Snyder M, Greon JJ, Neufeld HN, Goldbourt U, Riss E. Angina pectoris among 10,000 men. 5 year incidence and univariate analysis. Am J Med. 1973;55:583-594.
36. SAS Institute, Inc. The LIFETEST Procedure. In: SAS User's Guide: Statistics. 5th ed. Cary, NC: SAS Institute, Inc.; 1985;529-558.
37. Kramer MS. Life-table (survival) analysis. In: Clinical Epidemiology and Biostatistics. A Primer for Clinical Investigators and Decision-Makers. New York: Springer-Verlag; 1988;236-253.
38. SAS Institute, Inc. SAS technical report P-217. In: SAS/STAT Software: PHREG Procedure. 6th ed. Cary, NC: SAS Institute, Inc.; 1991:8-41.
39. Allison PD. Survival analysis using the SAS system: A practical guide. Cary NC: SAS Institute Inc., 1995. 292 p.
40. Brand FN, Abbott RD, Kannel WB. Diabetes, intermittent claudication, and risk of cardiovascular events. Diabetes. 1989;38:504-509.
41. Leng GC. Questionnaires. In: Fowkes FGR, ed. Epidemiology of Peripheral Vascular Disease. London: Springer-Verlag; 1991:29-40.